Knight Therapeutics Gets Regulatory Approval for TAVALISSE in Colombia

MT newswire2026/09/02 09:37

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

05:37 AM EDT, 09/02/2026 (MT Newswires) -- Knight Therapeutics (GUD.TO) has received approval from the Colombian health regulatory agency for TAVALISSE, used to treat patients with chronic immune thrombocytopenia. Knight expects to launch TAVALISSE in Colombia in the first half of 2027. It has been launched in Mexico in May 2026 and is scheduled to launch in Brazil in the fourth quarter of 2026.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Knight Therapeutics Gets Regulatory Approval for TAVALISSE in Colombia

You may also like

Crypto prices